These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31751477)

  • 41. Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia.
    de Viron E; Michaux L; Put N; Bontemps F; Van Den Neste E
    Leuk Lymphoma; 2012 Aug; 53(8):1445-51. PubMed ID: 22280536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T-prolymphocytic leukaemia and Sezary syndrome.
    Brito-Babapulle V; Hamoudi R; Matutes E; Watson S; Kaczmarek P; Maljaie H; Catovsky D
    Br J Haematol; 2000 Jul; 110(1):180-7. PubMed ID: 10930996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. B-cell prolymphocytic leukemia carrying t(8;14)(q24;q32), associated with both autoimmune hemolytic anemia and pure red cell aplasia.
    Iioka F; Akasaka T; Hayashida M; Okumura A; Ohno H
    J Clin Exp Hematop; 2014; 54(3):219-24. PubMed ID: 25501113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T-cell prolymphocytic leukemia with hemorrhagic gastrointestinal involvement and a new chromosomal abnormality.
    Toyota S; Nakamura N; Dan K
    Int J Hematol; 2002 Apr; 75(3):314-7. PubMed ID: 11999363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis.
    Bowen D; Groves MJ; Burnett AK; Patel Y; Allen C; Green C; Gale RE; Hills R; Linch DC
    Leukemia; 2009 Jan; 23(1):203-6. PubMed ID: 18596741
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical significance of detecting p53 protein in Burkitt lymphoma and B-cell acute lymphoblastic leukemia using immunocytochemistry.
    Nagai J; Kigasawa H; Koga N; Katoh A; Nishihira H; Nagao T
    Leuk Lymphoma; 1998 Feb; 28(5-6):591-7. PubMed ID: 9613990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
    Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
    Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T-cell prolymphocytic leukemia with a novel translocation (6;11)(q21;q23).
    Wong KF; Chan JK; Sin VC
    Cancer Genet Cytogenet; 1999 Jun; 111(2):149-51. PubMed ID: 10347553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Telomeric associations in a patient with B-cell prolymphocytic leukaemia.
    Howell RT; Kitchen C; Standen GR
    Genes Chromosomes Cancer; 1993 Jun; 7(2):116-8. PubMed ID: 7687453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Splenic B-Cell Lymphomas with Diffuse Cyclin D1 Protein Expression and Increased Prolymphocytic Cells: A Previously Unrecognized Diagnostic Pitfall.
    Algashaamy K; Tan Y; Mackrides N; Alencar A; Peng JH; Rosenblatt J; Alderuccio JP; Lossos IS; Vega F; Chapman J
    Case Rep Hematol; 2018; 2018():5761953. PubMed ID: 30363761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pediatric rhabdomyosarcoma translocation (2;13)(q35;q14) in B-prolymphocytic leukemia.
    Adami F; Sancetta R; Trentin L; Semenzato G; Stella M; Montaldi A; Chilosi M
    Leukemia; 1993 Oct; 7(10):1676-8. PubMed ID: 8412333
    [No Abstract]   [Full Text] [Related]  

  • 52. Rare skin manifestations successfully treated with primary B-cell chronic lymphocytic leukemia treatment.
    Wong SM; McComish J; Douglass J; Tsui A; Chee L
    J Cutan Pathol; 2016 Jun; 43(6):552-5. PubMed ID: 27103322
    [No Abstract]   [Full Text] [Related]  

  • 53. Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients.
    Fiegl M; Stauder R; Steurer M; Mian M; Hopfinger G; Brychtova Y; Skrabs C; Zabernigg A; Schmid F; Haslbaur F; Winder G; Walder A; Lang A; Voskova D; Greil R; Mayer J; Gastl G;
    Ann Hematol; 2014 Feb; 93(2):267-77. PubMed ID: 24292560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
    Babusíková O; Hrivnáková A; Klobusická M; Mesárosová A; Ujházy P
    Neoplasma; 1990; 37(6):693-701. PubMed ID: 2125699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study on the Prognostic Value of Aberrant Antigen in Patients With Acute B Lymphocytic Leukemia.
    Liu J; Tan X; Ma YY; Liu Y; Gao L; Gao L; Kong P; Peng XG; Zhang X; Zhang C
    Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e349-e358. PubMed ID: 31076372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T cell prolymphocytic leukemia with new chromosome rearrangements.
    Zver S; Kokalj Vokac N; Zagradisnik B; Erjavec A; Zagorac A; Zupan IP; Cernelc P
    Acta Haematol; 2004; 111(3):168-70. PubMed ID: 15034240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical features and diagnosis of hairy cell leukemia.
    Quest GR; Johnston JB
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):180-92. PubMed ID: 26614896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts.
    Troeger A; Glouchkova L; Escherich G; Siepermann M; Hanenberg H; Janka-Schaub G; Göbel U; Ackermann B; Dilloo D
    Klin Padiatr; 2008; 220(6):353-7. PubMed ID: 18949670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Karyotypic findings in a case of prolymphocytic leukemia with a history of radiation exposure.
    Sadamori N; Han T; Block AW; Sandberg AA
    Cancer Genet Cytogenet; 1983 Sep; 10(1):79-85. PubMed ID: 6309359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monosomal karyotype routinely defines a poor prognosis subgroup in acute myeloid leukemia and is frequently associated with TP53 deletion.
    Gaillard JB; Chiesa J; Reboul D; Arnaud A; Brun S; Donadio D; Exbrayat C; Wickenhauser S; Bourquard P; Jourdan E; Lavabre-Bertrand T
    Leuk Lymphoma; 2012 Feb; 53(2):336-7. PubMed ID: 21823831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.